Sound waves and immunotherapy join forces against deadly brain tumor
Disease control
Not yet recruiting
This early-stage study tests a new way to treat a type of aggressive brain cancer (glioblastoma) that has come back after standard treatment. It combines a focused ultrasound device that opens the blood-brain barrier with an immunotherapy drug called pembrolizumab. The main goal …
Phase: PHASE1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated May 26, 2026 12:06 UTC